ArticleFrontiers in medicine2026

Multiparametric MRI-based radiomics for differentiating HER2-negative, HER2-low, and HER2-positive breast cancer.

Lulu Gai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.